Brief: Crescita Therapeutics says Jose Darocha appointed CFO
10/11/2017 13:02
Nov 10 (Reuters) - Crescita Therapeutics Inc CTX.TO
* Crescita Therapeutics announces 2017 third quarter results
and
appoints new CFO
* Says Jose Darocha appointed CFO
* Crescita Therapeutics Inc - qtrly loss per share $0.03
from
continuing OPS
* Crescita Therapeutics Inc qtrly total revenue was $2.7
million
versus $1.1 million
Source text for Eikon: ID:nPn9H8DHca
Further company coverage: CTX.TO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium